...
首页> 外文期刊>Experimental and therapeutic medicine >Correlation of abdominal fat ratio with hepatic CT enhancement
【24h】

Correlation of abdominal fat ratio with hepatic CT enhancement

机译:腹部脂肪比例与肝脏CT增强的相关性

获取原文
获取原文并翻译 | 示例

摘要

The objective of the study was to evaluate the effect of abdominal fat proportion on hepatic computed tomography (CT) enhancement. CT data for 87 patients (47 men, mean age 55.09 +/- 13.27 years; 40 women, mean age 60.43 +/- 11.29 years) were analyzed by linear regression to assess the association of patient age and abdominal fat proportion with adjusted maximal hepatic enhancement (aMHE), calculated by dividing the maximal hepatic enhancement by the dose of iodine injected per kilogram of patient body weight, for each gender. The abdominal fat ratio (AFR) at the umbilical level, calculated as the volume of abdominal fat divided by the total abdominal volume, was used as a marker of abdominal fat proportion. It was found that aMHE was positively correlated with AFR for men (r=0.48, P<0.01) and women (r=0.46, P<0.01) but not with patient age (r=-0.09 and -0.14, respectively, both P>0.05). Therefore, it was concluded that determining an iodine dose on the basis of AFR might be an optimal way to maintain constant hepatic enhancement.
机译:这项研究的目的是评估腹部脂肪比例对肝脏计算机断层扫描(CT)增强的影响。通过线性回归分析分析了87例患者的CT数据(47例男性,平均年龄55.09 +/- 13.27岁; 40例女性,平均年龄60.43 +/- 11.29岁),以评估患者年龄和腹部脂肪比例与调整后的最大肝脏的相关性增强(aMHE),通过将最大肝脏增强除以每千克患者体重所注射的碘剂量(每种性别)来计算。脐带水平的腹部脂肪比率(AFR),用腹部脂肪的体积除以腹部总体积计算,用作腹部脂肪比例的标志。结果发现,男性(r = 0.48,P <0.01)和女性(r = 0.46,P <0.01)和患者年龄(r = -0.09和-0.14)aMHE与AFR均呈正相关,两者均无相关性。 > 0.05)。因此,可以得出结论,基于AFR确定碘剂量可能是维持恒定肝增强的最佳方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号